Stay updated with breaking news from Thomasa Schreck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX – Get Rating) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 860,000 shares, a growth of 12.3% from the May 15th total of 765,800 shares. Based on an average trading volume of 222,000 shares, the […]
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX – Get Rating) saw a significant decrease in short interest in May. As of May 15th, there was short interest totalling 765,800 shares, a decrease of 10.5% from the April 30th total of 855,800 shares. Based on an average trading volume of 204,900 shares, the short-interest ratio is currently 3.7 days. […]
AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Rating) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Thursday. AcelRx Pharmaceuticals Price Performance Shares of NASDAQ:ACRX traded up $0.08 on Thursday, reaching $0.79. 93,303 shares of the company traded hands, compared to its average […]
AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Rating) is set to release its earnings data after the market closes on Wednesday, May 10th. Analysts expect AcelRx Pharmaceuticals to post earnings of ($0.71) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link. AcelRx Pharmaceuticals (NASDAQ:ACRX […]
StockNews.com upgraded shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Rating) from a sell rating to a hold rating in a research report report published on Friday. AcelRx Pharmaceuticals Price Performance ACRX stock opened at $0.64 on Friday. The company’s 50-day moving average is $1.21 and its 200-day moving average is $2.72. The stock has a […]